Sensex 76024.51
1390.41 (-1.80%)

Nifty Healthcare Index

 Companies

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen:- Q: Quality, V: Valuation,PT: Price Trend

Nifty Healthcare Index companies as on Apr-2025 |
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks


Company Name (M.Cap)
DeciZen


CMP


Price
Change


Market
Cap (Cr)


52Week
High


52Week
Low


ROE


P/E


P/BV


EV/
EBITDA


5Y Sales
Gr.(%)


5Y Profit
Gr.(%)
More Info
1
Q V+ PT
1,118 1.92% 1,05,332 1,228
08 Jan, 25
743.0
31 May, 24
13.36 104.45 11.65 56.19 26.17 0.00
2
Q V PT
2,442 0.79% 1,01,358 3,050
23 Dec, 24
1,910
05 Aug, 24
20.88 51.79 7.13 34.02 19.33 29.77
3
Q V PT
1,152 0.73% 96,163 1,420
21 Aug, 24
1,093
12 Mar, 25
21.33 17.90 2.99 10.76 12.64 24.49
4
Q V PT
1,445 0.20% 1,16,664 1,702
09 Oct, 24
1,318
10 May, 24
15.88 23.38 3.90 15.00 9.51 24.56
5
Q V+ PT
6,630 0.11% 95,328 7,545
08 Nov, 24
5,691
04 Jun, 24
13.81 79.33 11.17 42.42 -2.69 26.09
6
Q V PT
4,864 -0.33% 57,795 6,440
17 Sep, 24
4,410
04 Jun, 24
17.76 25.33 4.64 19.71 11.27 17.59
7
Q V PT
339.1 -0.60% 40,718 404.6
21 Jan, 25
260.0
19 Apr, 24
8.64 67.63 3.55 111.01 -3.80 31.80
8
Q V PT
483.2 -0.80% 11,720 724.5
02 Sep, 24
382.1
15 Apr, 24
15.11 36.34 3.55 18.99 12.34 24.68
9
Q V PT
877.5 -0.93% 88,297 1,324
09 Aug, 24
859.1
04 Mar, 25
20.25 19.46 3.87 12.57 8.23 15.65
10
Q V+ PT
719.2 -0.95% 28,910 960.0
02 Dec, 24
608.0
04 Jun, 24
12.96 59.81 6.51 29.33 11.90 8.90
11
Q V+ PT
30,306 -1.38% 64,398 31,900
04 Mar, 25
25,200
25 Apr, 24
34.87 48.26 16.59 33.73 9.72 21.88
12
Q V+ PT
688.4 -1.45% 51,971 744.0
30 Dec, 24
406.4
04 Jun, 24
2.19 298.09 5.70 113.25 12.47 10.01
13
Q V+ PT
604.0 -1.60% 32,266 646.2
07 Feb, 25
386.9
04 Jun, 24
3.55 161.12 7.64 38.35 17.07 6.90
14
Q V+ PT
3,182 -1.64% 1,07,678 3,590
10 Oct, 24
2,509
16 Apr, 24
24.28 57.83 13.45 29.52 6.93 19.16
15
Q V PT
1,509 -2.03% 42,575 1,830
15 Oct, 24
974.9
02 Apr, 24
-14.66 0.00 4.84 13.35 3.67 -213.18
16
Q V PT
1,135 -2.14% 65,912 1,593
13 Sep, 24
1,031
04 Mar, 25
9.71 34.38 3.27 22.77 -2.78 4.44
17
Q V+ PT
1,697 -2.22% 4,07,155 1,960
30 Sep, 24
1,377
04 Jun, 24
16.82 35.61 5.65 24.18 10.78 22.72
18
Q V PT
1,956 -3.46% 89,322 2,403
02 Jan, 25
1,494
04 Jun, 24
14.31 31.14 5.41 17.76 6.41 36.90
19
Q V+ PT
5,549 -3.89% 1,47,295 6,449
02 Dec, 24
3,556
02 Apr, 24
12.01 71.26 10.30 45.50 9.66 3.51
20
Q V+ PT
1,393 -7.20% 35,346 1,758
03 Jan, 25
1,061
28 Jun, 24
9.67 45.28 5.04 23.69 11.18 4.98
×
×

Nifty Healthcare Index - Today's Top Gainers

Company Name CMP Price Change(%)
1,117.801.92%
2,442.300.79%
1,152.400.73%
1,444.550.20%
6,629.900.11%

Nifty Healthcare Index - Today's Top Losers

Company Name CMP Price Change(%)
1,393.20-7.20%
5,548.50-3.89%
1,956.40-3.46%
1,696.95-2.22%
1,134.85-2.14%

News about Nifty Healthcare Index

Glenmark Pharmaceuticals informs about disclosure

Glenmark Pharmaceuticals has informed that IGI Inc., wholly owned subsidiary of Glenmark Pharmaceuticals (the Company) has announced its plans to cease all CMC development and clinical supplies manufacturing at its facility in La Chaux-de-Fonds, Switzerland. In accordance with the Listing Regulations and SEBI Circular No SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, regarding the disclosure by listed entities under Regulation 30 of the Listing Regulations, we are providing the details of the intended closure of the aforementioned manufacturing facility herein below: Date of such binding agreement, if any, entered for sale of such unit/division, if any - Not Applicable ; Amount & percentage of turnover or revenue or income and net worth of the listed entity contributed by such unit or division during the last financial year – Turnover of plant - Rs. NIL (material is only used for captive consumption) Percentage to consolidated turnover of Company (1 April 2023 to 31 March 2024): NA Net worth of plant - Rs. 223.52 million (as of 31 March 2024); Estimated date of closure - 31 July 2025; Reasons for closure - IGI is progressing its pipeline and it is anticipated that higher quantities of finished product will be required for future clinical programs. IGI CMC development and manufacturing of ongoing and future clinical programs will be moved to a network of well-established Contract Development and Manufacturing Organizations (CDMOs); This closure will not adversely affect the Consolidated financials of the Company.

The above information is a part of company’s filings submitted to BSE.

29 Mar, 2025

All Indices


When to buy Bluechip stocks for highest returns?

Nifty Healthcare Index FAQs

You can use different criterias to arrive at the list of best stocks in the Nifty Healthcare Index company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Healthcare Index companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (M) Very Good 30,306 64,398 48.26 16.59 33.73 34.87
Torrent Pharmaceuticals Ltd. (L) Very Good 3,182 1,07,678 57.83 13.45 29.52 24.28
Dr. Reddys Laboratories Ltd. (L) Very Good 1,152 96,163 17.90 2.99 10.76 21.33
Mankind Pharma Ltd. (M) Very Good 2,442 1,01,358 51.79 7.13 34.02 20.88
Zydus Lifesciences Ltd. (L) Very Good 877.5 88,297 19.46 3.87 12.57 20.25

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Fortis Healthcare Ltd. (M) Not Good 688.4 51,971 60.71
Divis Laboratories Ltd. (L) Very Good 5,549 1,47,295 55.52
Glenmark Pharmaceuticals Ltd. (M) Somewhat Good 1,509 42,575 53.75
Laurus Labs Ltd. (S) Very Good 604.0 32,266 47.61
Max Healthcare Institute Ltd. (M) N/A 1,118 1,05,332 33.02
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Max Healthcare Institute Ltd. (M) N/A 1,118 1,05,332 104.5 11.65 56.19 26.17
Mankind Pharma Ltd. (M) Very Good 2,442 1,01,358 51.79 7.13 34.02 19.33
Laurus Labs Ltd. (S) Very Good 604.0 32,266 161.1 7.64 38.35 17.07
Dr. Reddys Laboratories Ltd. (L) Very Good 1,152 96,163 17.90 2.99 10.76 12.64
Fortis Healthcare Ltd. (M) Not Good 688.4 51,971 298.1 5.70 113.2 12.47

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Lupin Ltd. (M) Somewhat Good 1,956 89,322 31.14 5.41 17.76 36.90
Biocon Ltd. (M) Somewhat Good 339.1 40,718 67.63 3.55 111.0 31.80
Mankind Pharma Ltd. (M) Very Good 2,442 1,01,358 51.79 7.13 34.02 29.77
Apollo Hospitals Enterprise Ltd. (M) Somewhat Good 6,630 95,328 79.33 11.17 42.42 26.09
Granules India Ltd. (S) Very Good 483.2 11,720 36.34 3.55 18.99 24.68
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...